ltx-315
Biologicalexperimental
Clinical trial activity
7 trials · 16 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2010 (NCT01058616)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ltx-315
- ltx-315
- ltx-315
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06651151 | Phase 2 | Nov 1, 2024 | Lytix Biopharma AS, University of Oslo |
| NCT05188729 | Phase 2 | Feb 1, 2022 | HeartcoR Solutions, Myonex, Q2 solutions, Veristat, Inc., Verrica Pharmaceuticals Inc. |
| NCT04796194 | Phase 2 | Jun 1, 2021 | Covance, Lytix Biopharma AS, University of Texas at Houston |
| NCT03725605 | Phase 2 | Dec 28, 2018 | Lytix Biopharma AS, University of Copenhagen |
| NCT01986426 | Phase 1 | Nov 1, 2013 | ICON, Lytix Biopharma AS, Theradex, University of London |
| NCT01223209 | Phase 1 | Aug 1, 2010 | Kael-GemVax Co., Ltd., Lytix Biopharma AS |
| NCT01058616 | Phase 1 | Jan 1, 2010 | Karolinska Institute, Lytix Biopharma AS, Osaka University, University of Oslo |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (16)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Lytix Biopharma AS | For profit | 6 | 5 | 2 | 2010 |
| University of Oslo | Academic/Hospital | 2 | 1 | 2 | 2010 |
| Covance | For profit | 1 | 0 | 1 | 2021 |
| HeartcoR Solutions | For profit | 1 | 0 | 1 | 2022 |
| ICON | For profit | 1 | 0 | 1 | 2013 |
| Kael-GemVax Co., Ltd. | For profit | 1 | 0 | 1 | 2010 |
| Karolinska Institute | Academic/Hospital | 1 | 0 | 1 | 2010 |
| Myonex | For profit | 1 | 0 | 1 | 2022 |
| Osaka University | Academic/Hospital | 1 | 0 | 1 | 2010 |
| Q2 solutions | For profit | 1 | 0 | 1 | 2022 |
| Theradex | For profit | 1 | 0 | 1 | 2013 |
| University of Copenhagen | Academic/Hospital | 1 | 0 | 1 | 2018 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2013 |
| University of Texas at Houston | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Veristat, Inc. | For profit | 1 | 0 | 1 | 2022 |
| Verrica Pharmaceuticals Inc. | For profit | 1 | 1 | 1 | 2022 |
16 organizations
Page 1 / 1